AAAAAA

   
Results: 1-14 |
Results: 14
DRUG-NAIVE PATIENTS WITH PARKINSONS-DISEASE IN HOEHN AND YAHR STAGE-IAND STAGE-II SHOW A BILATERAL DECREASE IN STRIATAL DOPAMINE TRANSPORTERS AS REVEALED BY [I-123] BETA-CIT SPECT
Authors: TISSINGH G BERGMANS P BOOIJ J WINOGRODZKA A VANROYEN EA STOOF JC WOLTERS EC
Citation: G. Tissingh et al., DRUG-NAIVE PATIENTS WITH PARKINSONS-DISEASE IN HOEHN AND YAHR STAGE-IAND STAGE-II SHOW A BILATERAL DECREASE IN STRIATAL DOPAMINE TRANSPORTERS AS REVEALED BY [I-123] BETA-CIT SPECT, Journal of neurology, 245(1), 1998, pp. 14-20
L-2-BETA-CARBOMETHOXY-3-BETA-(4-IODOPHENYL)TROPANE SPECT IN HEALTHY CONTROLS AND EARLY-STAGE, DRUG-NAIVE PARKINSONS-DISEASE
Authors: TISSINGH G BOOIJ J BERGMANS P WINOGRODZKA A JANSSEN AGM VANROYEN EA STOOF JC WOLTERS EC
Citation: G. Tissingh et al., L-2-BETA-CARBOMETHOXY-3-BETA-(4-IODOPHENYL)TROPANE SPECT IN HEALTHY CONTROLS AND EARLY-STAGE, DRUG-NAIVE PARKINSONS-DISEASE, The Journal of nuclear medicine, 39(7), 1998, pp. 1143-1148
IMAGING OF DOPAMINE TRANSPORTERS WITH IODINE-123-FP-CIT SPECT IN HEALTHY CONTROLS AND PATIENTS WITH PARKINSONS-DISEASE
Authors: BOOIJ J HABRAKEN JBA BERGMANS P TISSINGH G WINOGRODZKA A WOLTERS EC JANSSEN AGM STOOF JC VANROYEN EA
Citation: J. Booij et al., IMAGING OF DOPAMINE TRANSPORTERS WITH IODINE-123-FP-CIT SPECT IN HEALTHY CONTROLS AND PATIENTS WITH PARKINSONS-DISEASE, The Journal of nuclear medicine, 39(11), 1998, pp. 1879-1884
DEPRESSION IN PARKINSONS-DISEASE - THE IMPACT OF SYMPTOM OVERLAP ON PREVALENCE
Authors: HOOGENDIJK WJG SOMMER C TISSINGH G DEEG DJH WOLTERS EC
Citation: Wjg. Hoogendijk et al., DEPRESSION IN PARKINSONS-DISEASE - THE IMPACT OF SYMPTOM OVERLAP ON PREVALENCE, Psychosomatics, 39(5), 1998, pp. 416-421
[I-123] BETA-CIT SINGLE-PHOTON EMISSION TOMOGRAPHY IN PARKINSONS-DISEASE REVEALS A SMALLER DECLINE IN DOPAMINE TRANSPORTERS WITH AGE THAN IN CONTROLS
Authors: TISSINGH G BERGMANS P BOOIJ J WINOGRODZKA A STOOF JC WOLTERS EC VANROYEN EA
Citation: G. Tissingh et al., [I-123] BETA-CIT SINGLE-PHOTON EMISSION TOMOGRAPHY IN PARKINSONS-DISEASE REVEALS A SMALLER DECLINE IN DOPAMINE TRANSPORTERS WITH AGE THAN IN CONTROLS, European journal of nuclear medicine, 24(9), 1997, pp. 1171-1174
PRACTICAL BENEFIT OF [I-123] FP-CIT SPET IN THE DEMONSTRATION OF THE DOPAMINERGIC DEFICIT IN PARKINSONS-DISEASE
Authors: BOOIJ J TISSINGH G WINOGRODZKA A BOER GJ STOOF JC WOLTERS EC VANROYEN EA
Citation: J. Booij et al., PRACTICAL BENEFIT OF [I-123] FP-CIT SPET IN THE DEMONSTRATION OF THE DOPAMINERGIC DEFICIT IN PARKINSONS-DISEASE, European journal of nuclear medicine, 24(1), 1997, pp. 68-71
RCBF SPECT IN PARKINSONS-DISEASE PATIENTS WITH MENTAL DYSFUNCTION
Authors: BISSESSUR S TISSINGH G WOLTERS EC SCHELTENS P
Citation: S. Bissessur et al., RCBF SPECT IN PARKINSONS-DISEASE PATIENTS WITH MENTAL DYSFUNCTION, Journal of neural transmission. Supplementum, (50), 1997, pp. 25-30
IBZM-SPECT AND CIT-SPECT OF THE DOPAMINERGIC SYSTEM IN PARKINSONISM
Authors: TISSINGH G BOOIJ J WINOGRODZKA A VANROYEN EA WOLTERS EC
Citation: G. Tissingh et al., IBZM-SPECT AND CIT-SPECT OF THE DOPAMINERGIC SYSTEM IN PARKINSONISM, Journal of neural transmission. Supplementum, (50), 1997, pp. 31-37
NIGROSTRIATAL DOPAMINERGIC IMAGING WITH IODINE-123-BETA-CIT-FP SPECT AND FLUORINE-18-FDOPA/PET/
Authors: TISSINGH G BERGMANS P WINOGRODZKA A STOOF JC WOLTERS EC BOOIJ J VANROYEN EA
Citation: G. Tissingh et al., NIGROSTRIATAL DOPAMINERGIC IMAGING WITH IODINE-123-BETA-CIT-FP SPECT AND FLUORINE-18-FDOPA/PET/, The Journal of nuclear medicine, 38(8), 1997, pp. 1271-1272
[I-123] FP-CIT SPECT DISCRIMINATES BETWEEN GROUPS OF EARLY NONMEDICATED PATIENTS WITH PARKINSONS-DISEASE AND CONTROLS
Authors: BOOIJ J TISSINGH G BERGMANS P COSTA DC WINOGRODZKA A JANSSEN AGM WOLTERS EC STOOF JC VANROYEN EA
Citation: J. Booij et al., [I-123] FP-CIT SPECT DISCRIMINATES BETWEEN GROUPS OF EARLY NONMEDICATED PATIENTS WITH PARKINSONS-DISEASE AND CONTROLS, The Journal of nuclear medicine, 38(5), 1997, pp. 518-518
[I-123] FP-CIT SPECT SHOWS A PRONOUNCED DECLINE OF STRIATAL DOPAMINE TRANSPORTER LABELING IN EARLY AND ADVANCED PARKINSONS-DISEASE
Authors: BOOIJ J TISSINGH G BOER GJ SPEELMAN JD STOOF JC JANSSEN AGM WOLTERS EC VANROYEN EA
Citation: J. Booij et al., [I-123] FP-CIT SPECT SHOWS A PRONOUNCED DECLINE OF STRIATAL DOPAMINE TRANSPORTER LABELING IN EARLY AND ADVANCED PARKINSONS-DISEASE, Journal of Neurology, Neurosurgery and Psychiatry, 62(2), 1997, pp. 133-140
[I-123] FP-CIT SPECT REVEALS MARKED DECLINE OF STRIATAL SIGNAL IN PARKINSONS-DISEASE MEASURABLE 3H POST-INJECTION
Authors: BOOIJ J COSTA DC TISSINGH G BOER GJ JANSSEN AGM SPEELMAN JD WOLTERS EC STOOF JC VANROYEN EA
Citation: J. Booij et al., [I-123] FP-CIT SPECT REVEALS MARKED DECLINE OF STRIATAL SIGNAL IN PARKINSONS-DISEASE MEASURABLE 3H POST-INJECTION, The Journal of nuclear medicine, 37(5), 1996, pp. 525-525
EVALUATION OF [I-123] BETA-CIT BINDING WITH SPECT IN CONTROLS, EARLY AND LATE PARKINSONS-DISEASE
Authors: VERMEULEN RJ WOLTERS RC TISSINGH G BOOIJ J JANSSEN AGM HABRAKEN J SOKOLEBUSEMANN E STOOF JC VANROYEN EA
Citation: Rj. Vermeulen et al., EVALUATION OF [I-123] BETA-CIT BINDING WITH SPECT IN CONTROLS, EARLY AND LATE PARKINSONS-DISEASE, Nuclear medicine and biology, 22(8), 1995, pp. 985-991
DOPAMINE AGONISTS IN PARKINSONS-DISEASE
Authors: WOLTERS EC TISSINGH G BERGMANS PLM KUIPER MA
Citation: Ec. Wolters et al., DOPAMINE AGONISTS IN PARKINSONS-DISEASE, Neurology, 45(3), 1995, pp. 28-34
Risultati: 1-14 |